Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.760
+0.070 (4.14%)
At close: Dec 5, 2025, 4:00 PM EST
1.714
-0.046 (-2.63%)
After-hours: Dec 5, 2025, 4:59 PM EST
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $12.39 million as of December 5, 2025. Its market cap has increased by 74.17% in one year.
Market Cap
12.39M
Enterprise Value
24.57K
1-Year Change
74.17%
Ranking
Category
Stock Price
$1.76
Market Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has decreased from $37.12M to $12.39M, a decrease of -66.63%. That is a compound annual growth rate of -15.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 12.39M | 112.62% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | 44.72M | 45.35% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |